Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Common Stock [Member]	Stock Subscriptions Receivable [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]	Stockholders' Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning Balance at Sep. 30, 2017	$ 500	$ 50	$ 83	$ 1,073		$ 7,657,982	$ (7,592,371)		$ 67,317	$ 158,124	$ 225,441
Beginning Balance, shares at Sep. 30, 2017	5,000,000	500,000	832,500	10,732,922
Net income (loss)							(986,592)		(986,592)	(7,890)	(994,482)
Change in foreign currency translation
Issuance of common stock in connection with the conversion of Series D preferred stock			$ (9)	$ 22		(13)
Issuance of common stock in connection with the conversion of Series D preferred stock, shares			(87,728)	219,320
Issuance of common stock in connection with sales made under private offerings				$ 125		497,875			498,000		498,000
Issuance of common stock in connection with sales made under private offerings, shares				1,245,000
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors				$ 2		6,562			6,564		6,564
Issuance of common stock as compensation to employees, officers and/or directors, shares				15,000
Issuance of common stock in exchange for consulting, professional and other services provided				$ 24		241,133			241,157		241,157
Issuance of common stock in exchange for consulting, professional and other services provided, shares				239,750
Issuance of common stock in connection with the settlement of accounts payable				$ 4		18,746			18,750		18,750
Issuance of common stock in connection with the settlement of accounts payable, shares				37,500
Issuance of common stock in connection with the settlement of notes payable				$ 32		161,968			162,000		162,000
Issuance of common stock in connection with the settlement of notes payable, shares				324,000
Issuance of common stock in connection with the conversion of loans payable				$ 90		318,910			319,000		319,000
Issuance of common stock in connection with the conversion of loans payable, shares				900,793
Issuance of common stock in connection with the conversion of related party notes payable				$ 13		62,487			62,500		62,500
Issuance of common stock in connection with the conversion of related party notes payable, shares				125,000
Issuance of common stock in connection with the conversion of interest payable				$ 5		17,879			17,884		17,884
Issuance of common stock in connection with the conversion of interest payable, shares				50,743
Common stock options issued under employee equity incentive plan						72,587			72,587		72,587
Reclassification of derivative liability to additional paid-in capital						281,315			281,315		281,315
Recognition of beneficial conversion features related to convertible debt instruments
Acquisition of equity interests in subsidiaries
Ending Balance at Dec. 31, 2017	$ 500	$ 50	$ 74	$ 1,390		9,337,431	(8,578,963)		760,482	150,234	910,716
Ending Balance, shares at Dec. 31, 2017	5,000,000	500,000	744,772	13,890,028
Beginning Balance at Sep. 30, 2017	$ 500	$ 50	$ 83	$ 1,073		7,657,982	(7,592,371)		67,317	158,124	225,441
Beginning Balance, shares at Sep. 30, 2017	5,000,000	500,000	832,500	10,732,922
Net income (loss)											(2,679,190)
Change in foreign currency translation
Reclassification of derivative liability to additional paid-in capital											882,454
Ending Balance at Mar. 31, 2018	$ 500	$ 50	$ 55	$ 1,607		12,925,708	(10,258,765)		2,669,155	545,328	3,214,483
Ending Balance, shares at Mar. 31, 2018	5,000,000	500,000	552,500	16,068,505
Beginning Balance at Dec. 31, 2017	$ 500	$ 50	$ 74	$ 1,390		9,337,431	(8,578,963)		760,482	150,234	910,716
Beginning Balance, shares at Dec. 31, 2017	5,000,000	500,000	744,772	13,890,028
Net income (loss)							(1,679,802)		(1,679,802)	(4,906)	(1,684,708)
Change in foreign currency translation
Issuance of common stock in connection with the conversion of Series D preferred stock			$ (19)	$ 48		(29)
Issuance of common stock in connection with the conversion of Series D preferred stock, shares			(192,272)	480,680
Issuance of common stock in connection with sales made under private offerings				$ 2		9,998			10,000		10,000
Issuance of common stock in connection with sales made under private offerings, shares				25,000
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors				$ 5		160,890			160,895		160,895
Issuance of common stock as compensation to employees, officers and/or directors, shares				45,000
Issuance of common stock in exchange for consulting, professional and other services provided				$ 1		38,251			38,252		38,252
Issuance of common stock in exchange for consulting, professional and other services provided, shares				15,000
Issuance of common stock in connection with the settlement of accounts payable
Issuance of common stock in connection with the settlement of accounts payable, shares
Issuance of common stock in connection with the settlement of notes payable
Issuance of common stock in connection with the settlement of notes payable, shares
Issuance of common stock in connection with the conversion of loans payable				$ 97		384,118			384,215		384,215
Issuance of common stock in connection with the conversion of loans payable, shares				968,857
Issuance of common stock in connection with the conversion of related party notes payable
Issuance of common stock in connection with the conversion of related party notes payable, shares
Issuance of common stock in connection with the conversion of interest payable				$ 2		9,384			9,386		9,386
Issuance of common stock in connection with the conversion of interest payable, shares				23,669
Common stock options issued under employee equity incentive plan						995,181			995,181		995,181
Reclassification of derivative liability to additional paid-in capital						601,139			601,139		601,139
Issuance of common stock in satisfaction of debt issuances costs				$ 62		1,389,345			1,389,407		1,389,407
Issuance of common stock in satisfaction of debt issuances costs, shares				620,271
Issuance of common stock in connection with the conversion of debentures
Issuance of common stock in connection with the conversion of debentures, shares
Recognition of beneficial conversion features related to convertible debt instruments
Acquisition of equity interests in subsidiaries										400,000	400,000
Ending Balance at Mar. 31, 2018	$ 500	$ 50	$ 55	$ 1,607		12,925,708	(10,258,765)		2,669,155	545,328	3,214,483
Ending Balance, shares at Mar. 31, 2018	5,000,000	500,000	552,500	16,068,505
Beginning Balance at Sep. 30, 2018	$ 500	$ 50	$ 55	$ 2,326		21,495,621	(19,226,462)	(263,985)	2,008,105	1,934,634	3,942,739
Beginning Balance, shares at Sep. 30, 2018	5,000,000	500,000	552,500	23,255,411
Net income (loss)							(2,596,659)		(2,596,659)	(54,738)	(2,651,397)
Change in foreign currency translation								(179,822)	(179,822)		(179,822)
Issuance of common stock in connection with the conversion of Series D preferred stock			$ (4)	$ 10		(6)			(1)		(1)
Issuance of common stock in connection with the conversion of Series D preferred stock, shares			(38,000)	95,000
Issuance of common stock in connection with sales made under private offerings				$ 20		105,980			106,000		106,000
Issuance of common stock in connection with sales made under private offerings, shares				200,000
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors				$ 5		35,870			35,875		35,875
Issuance of common stock as compensation to employees, officers and/or directors, shares				50,000
Issuance of common stock in exchange for consulting, professional and other services provided				$ 25		128,375			128,400		128,400
Issuance of common stock in exchange for consulting, professional and other services provided, shares				250,000
Issuance of common stock in connection with the conversion of loans payable				$ 78		317,022			317,100		317,100
Issuance of common stock in connection with the conversion of loans payable, shares				779,808
Issuance of common stock in connection with the conversion of interest payable				$ 1		2,987			2,988		2,988
Issuance of common stock in connection with the conversion of interest payable, shares				10,163
Issuance of common stock in connection with the conversion of debentures				$ 67		387,933			388,000		388,000
Issuance of common stock in connection with the conversion of debentures, shares				669,362
Issuance of common stock and common stock purchase warrants in satisfaction of debt issuances costs						12,423			12,423		12,423
Recognition of beneficial conversion features related to convertible debt instruments						280,144			280,144		280,144
Stock based compensation related to employee stock options						169,922			169,922		169,922
Ending Balance at Dec. 31, 2018	$ 500	$ 50	$ 51	$ 2,531		22,936,272	(21,823,121)	(443,807)	672,476	1,879,896	2,552,372
Ending Balance, shares at Dec. 31, 2018	5,000,000	500,000	514,500	25,309,744
Beginning Balance at Sep. 30, 2018	$ 500	$ 50	$ 55	$ 2,326		21,495,621	(19,226,462)	(263,985)	2,008,105	1,934,634	3,942,739
Beginning Balance, shares at Sep. 30, 2018	5,000,000	500,000	552,500	23,255,411
Net income (loss)											(6,489,767)
Change in foreign currency translation											(115,561)
Reclassification of derivative liability to additional paid-in capital
Ending Balance at Mar. 31, 2019	$ 500	$ 50	$ 35	$ 2,709	(406,000)	24,278,682	(25,554,846)	(379,546)	(2,058,416)	1,773,251	(285,165)
Ending Balance, shares at Mar. 31, 2019	5,000,000	500,000	349,500	27,094,744
Beginning Balance at Dec. 31, 2018	$ 500	$ 50	$ 51	$ 2,531		22,936,272	(21,823,121)	(443,807)	672,476	1,879,896	2,552,372
Beginning Balance, shares at Dec. 31, 2018	5,000,000	500,000	514,500	25,309,744
Net income (loss)							(3,731,725)		(3,731,725)	(106,645)	(3,838,400)
Change in foreign currency translation								64,261	64,261		(115,561)
Issuance of common stock in connection with the conversion of Series D preferred stock			$ (16)	$ 41		(24)			1		1
Issuance of common stock in connection with the conversion of Series D preferred stock, shares			(165,000)	412,500
Issuance of common stock in connection with sales made under private offerings				$ 20		79,980			80,000		80,000
Issuance of common stock in connection with sales made under private offerings, shares				200,000
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors				$ 4		19,496			19,500		19,500
Issuance of common stock as compensation to employees, officers and/or directors, shares				37,500
Issuance of common stock in exchange for consulting, professional and other services provided				$ 10		52,990			53,000		53,000
Issuance of common stock in exchange for consulting, professional and other services provided, shares				100,000
Issuance of common stock and common stock purchase warrants in satisfaction of debt issuances costs				$ 2		46,675			46,677		46,677
Issuance of common stock and common stock purchase warrants in satisfaction of debt issuances costs, shares				20,000
Issuance of common stock in connection with stock subscriptions received under private offerings				$ 101	(406,000)	405,899
Issuance of common stock in connection with stock subscriptions received under private offerings, shares				1,015,000
Recognition of beneficial conversion features related to convertible debt instruments						566,841			566,841		566,841
Stock based compensation related to employee stock options						170,553			170,553		170,553
Ending Balance at Mar. 31, 2019	$ 500	$ 50	$ 35	$ 2,709	$ (406,000)	$ 24,278,682	$ (25,554,846)	$ (379,546)	$ (2,058,416)	$ 1,773,251	$ (285,165)
Ending Balance, shares at Mar. 31, 2019	5,000,000	500,000	349,500	27,094,744